Showing results (321-330 of 369) with videos related to
Sort By:
Pageof 37
Ebiomedicine|December 28, 2021
Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trialLei Shi, Xin Yuan, Weiqi Yao, et al.Gut|April 1, 2022
Single-cell RNA sequencing reveals intrahepatic and peripheral immune characteristics related to disease phases in HBV-infected patientsChao Zhang, Jiesheng Li, Yongqian Cheng, et al.Antiviral Research|July 7, 2025
Assessment of significant hepatic damage in young patients with chronic hepatitis B to initiate the antiviral treatment: The APLB scoreYi-Fan Guo, Yihui Rong, Yan-Ping Chen, et al.Emerging Microbes & Infections|March 26, 2025
GNLY+CD8+ T cells bridge premature aging and persistent inflammation in people living with HIVHui-Fang Wang, Chao Zhang, Li-Ping Zhang, et al.Signal Transduction and Targeted Therapy|May 7, 2021
HLA-mismatched allogeneic adoptive immune therapy in severely immunosuppressed AIDS patientsRuonan Xu, Ji-Yuan Zhang, Bo Tu, et al.Nature Immunology|August 14, 2020
Single-cell landscape of immunological responses in patients with COVID-19Ji-Yuan Zhang, Xiang-Ming Wang, Xudong Xing, et al.European Journal of Immunology|May 11, 2021
Compromised long-lived memory CD8+ T cells are associated with reduced IL-7 responsiveness in HIV-infected immunological nonrespondersMing-Ju Zhou, Hui-Huang Huang, Jin-Wen Song, et al.Cancer Medicine|June 3, 2024
Omicron neutralization character in patients with breast cancer and liver cancer after the nationwide omicron outbreakShaohua Zhang, Lili Tang, Chunmei Bao, et al.Signal Transduction and Targeted Therapy|August 29, 2020
Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trialFanping Meng, Ruonan Xu, Siyu Wang, et al.Hepatology International|June 17, 2025
Functional cure with new antiviral therapy for hepatitis B virus: a systematic review and meta-analysisJing Chen, Dong Ji, Jidong Jia, et al.Pageof 37